International quality assurance – all Huvitz products are certified by the international quality assurance system.
Euro-Optics are committed to bringing practitioners the latest internationally renowned optical instrument and equipment at highly competitive prices.
Our products are with cutting edge technology of the future which makes them one of the worlds most reliable and accurate instruments and is backed by factory trained technicians.
All instruments have the CE, FDA, ISO 9002, TUV and Canadian Quality Certificates
Contact Us on either of these numbers
Rihaz: 082 414 1472
Faisal: 079 242 2817
If not we are available, please WhatsApp your request to us
For quotations please send email to sales@eurotechoptical.com
and cc to quotations@eurotechoptical.com
For personal information send only to sales@eurotechoptical.com
For additional assistance email rihaz@eurotechoptical.com
HUVITZ – THE INTERNATIONAL BRAND WITH COMPETITIVE PRICING AND QUALITY
 |
Please be an Instagram friend with Huvitz. It brings you news in real time. |
Crafter Eye Clinic
We are proud to announce that Espansione Group’s propietary eye-light® platform has been offically recognized in the TFOS DEWS III Management and Therapy Report, the global gold standard in dry eye disease care.
Published in the American Journal of Ophthalmology, the TFOS DEWS III Report acknowledges Photobiomodulation Low-level Light Therapy (LLLT) — delivered through our eye-light® device — as an effective, evidence-backed approach for managing tear film instability, meibomian gland dysfunction, and inflammatory conditions of the ocular surface.
Key Highlights:
-
eye-light® is recognized as validated therapeutic tool for improving tear film stability and supporting DED management
-
LLLT can be applied directly to the eyelids — safely across all skin types — and is shown to improve both symptoms and tear volume.
-
Combined IPL + LLLT therapy using eye-light® demonstrated significant improvements in OSDI score, MGD grading and TBUT (Source Stonecipher et al., 2019; Giannaccare et al., 2023)
-
Blue LLLT reduces lid-margin bacterial load, offering potential in managing blepharitis and biofilm-related inflammation
Why It Matters
Being featured in the TFOS DEWS III Report is a powerful endorsement of our platform and a meaningful step forward in our mission to redefine how ocular surface diseases are managed — non-invasively and effectively.
